Needham Maintains Buy on Boston Scientific, Lowers Price Target to $48
Benzinga Newsdesk 4 days ago
Analyst RatingsNewsPrice TargetHot
Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $48.
Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $48.